ISRG Intuitive Surgical Inc.

JustRight Surgical and Intuitive Surgical Ink Deal That Expands Reach of Breakthrough Laparoscopic Technology

JustRight Surgical, LLC, the company pioneering mini-laparoscopic surgical instruments, today announced it has entered into a licensing agreement with Intuitive Surgical (NASDAQ: ISRG), a global technology leader in robotic-assisted minimally invasive surgery. The agreement provides Intuitive Surgical with a worldwide, exclusive license to JustRight Surgical’s intellectual property in energy-based vessel sealing and tissue stapling technologies for use in the robotics field. The deal also includes joint product development and an equity financing arrangement.

This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20170809005192/en/

JustRight Surgical's tiny new laparoscopic surgery technology permanently fuses vessels while using  ...

JustRight Surgical's tiny new laparoscopic surgery technology permanently fuses vessels while using significantly less energy, a major advance in safety. (Photo: Business Wire).

“We are excited to team up with Intuitive Surgical to expand the impact of JustRight Surgical’s technology beyond pediatric patients,” said Robert Kline, CEO of JustRight Surgical. “Our Low Power Vessel Sealing technology and Mini Mechanical Stapler combined with Intuitive Surgical’s minimally invasive expertise will now have the potential to improve safety and outcomes for adult-sized patients undergoing robotic surgery.”

JustRight’s low power vessel sealing technology permanently fuses vessels while using significantly less energy, a major advance in safety when performing minimally invasive surgical procedures.

In part due to such advances, the global laparoscopic instruments market is projected to reach USD 11.68 Billion by 2021, growing at a CAGR of 8.9 % from 2016 to 2021, according to a Markets and Markets industry report. The growth is also attributable to growing patient and physician preferences for laparoscopic surgery.

CEO Kline added, “The collaboration with Intuitive Surgical marks a major milestone for JustRight. The entry into adult robotic surgery significantly expands the reach and applicability of our mission of enabling safer and more precise laparoscopic surgery through the delivery of exceptional surgical technologies and instruments.”

About JustRight Surgical

JustRight Surgical, LLC develops and markets mini-laparoscopic surgical devices that improve and enable laparoscopic procedures in patients where access is limited and visibility reduced. JustRight’s technology was developed by a proven team of medical device professionals working closely with world-renowned surgeons. JustRight is the first and only company to secure FDA clearance for a low-power electrosurgical device, the 3mm JustRight Vessel Sealing System, to be used specifically for pediatric patients. The Company also developed the world’s first 5mm Mechanical Stapler with a pediatric indication. JustRight Surgical instruments are currently in use in more than 100 children's hospitals in the U.S. and Europe.

EN
09/08/2017

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Intuitive Surgical Inc.

 PRESS RELEASE

Da Vinci 5 Cleared for Cardiac Procedures

Da Vinci 5 Cleared for Cardiac Procedures FDA 510(k) clearance expands da Vinci 5 indications to include certain cardiac procedures SUNNYVALE, Calif., Jan. 26, 2026 (GLOBE NEWSWIRE) -- Intuitive (NASDAQ: ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today announced that the U.S. Food and Drug Administration (FDA) has cleared the da Vinci 5 system for certain cardiac procedures, including mitral valve repair and IMA (internal mammary artery) mobilization for cardiac revascularization.         Cardiovascular disease remains the l...

 PRESS RELEASE

20 Million Patients Benefit from da Vinci Surgery Globally

20 Million Patients Benefit from da Vinci Surgery Globally Achievement reflects the dedication of surgeons and care teams worldwide to improving patient outcomes through use of Intuitive’s minimally invasive technologies SUNNYVALE, Calif., Jan. 23, 2026 (GLOBE NEWSWIRE) -- Intuitive (NASDAQ: ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, announced that more than 20 million patients worldwide have been operated on by surgeons using da Vinci surgical systems. The milestone was reached as of the end of 2025, with more than 3.1 mil...

 PRESS RELEASE

Intuitive Announces Fourth Quarter Earnings

Intuitive Announces Fourth Quarter Earnings SUNNYVALE, Calif., Jan. 22, 2026 (GLOBE NEWSWIRE) -- Intuitive (the “Company”) (Nasdaq: ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today announced financial results for the quarter ended December 31, 2025. Q4 Highlights Worldwide procedures (da Vinci and Ion combined) grew approximately 18% compared with the fourth quarter of 2024. Da Vinci procedures grew approximately 17% and Ion procedures grew approximately 44%.The Company placed 532 da Vinci surgical systems, compared with...

 PRESS RELEASE

Intuitive Announces Preliminary Fourth Quarter and Full Year 2025 Resu...

Intuitive Announces Preliminary Fourth Quarter and Full Year 2025 Results SUNNYVALE, Calif., Jan. 14, 2026 (GLOBE NEWSWIRE) -- Intuitive (the “Company”) (Nasdaq: ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today announced certain unaudited preliminary fourth quarter and full year 2025 financial results ahead of its presentation at the 44th Annual J.P. Morgan Healthcare Conference on January 14, 2026. Financial and Operational Highlights Fourth quarter 2025 worldwide procedures (da Vinci and Ion combined) grew approximately 18...

 PRESS RELEASE

Intuitive Announces Expanded Indications for da Vinci SP

Intuitive Announces Expanded Indications for da Vinci SP FDA clearance expands da Vinci SP indications to include inguinal hernia repair, cholecystectomy, and appendectomy SUNNYVALE, Calif., Dec. 10, 2025 (GLOBE NEWSWIRE) -- Intuitive (NASDAQ: ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today announced that the U.S. Food and Drug Administration (FDA) has cleared the da Vinci Single Port (SP) surgical system for use in inguinal hernia repair, cholecystectomy, and appendectomy procedures. These clearances expand da Vinci SP’s ...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch